🇺🇸 FDA
Patent

US 11173145

Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase

granted A61KA61K31/015A61K31/166

Quick answer

US patent 11173145 (Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase) held by The Board of Regents of the University of Texas System expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/015, A61K31/166, A61K31/18, A61K31/351